AI + a16z with Vijay Pande

<p>A labor and delivery nurse who ran Senate healthcare policy now manages $1.7 trillion in federal health spending—and she runs her team like a startup.</p><p>Steph Carlton, Chief of Staff and Deputy Administrator at CMS, reveals the OKRs driving Medicare and Medicaid, why they' ... Show More

<p>Drug discovery has doubled the flow of candidates, but approvals remain roughly flat. The constraint is development, not discovery. </p><p>In this episode, a16z General Partner, Jorge Conde talks with Formation Bio cofounder and CEO Ben Liu about building a modern pharma compa ... Show More

<p>Josh Weiner left Meta to return to CVS Health with two painful realizations: consumers don't manage their health—they expect it, and the healthcare market fundamentally violates every principle of economics. In this conversation with a16z's Julie Yoo, the CVS Senior VP explain ... Show More

Jon Krohn talks to Varun Godbole about AI prompt engineering, generative wisdom, and AI generalists in this episode all about the interrelationships between humans and AI. Additional materials: www.superdatascience.com/869 This episode is brought to you by the Dell AI Factory w ... Show More

<p>In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Dr. Vijay Pande, a general partner at Andreessen Horowitz (A16Z) where he leads investments in health care and life sciences. The conversation explores Pande’s journey from academia to venture ca ... Show More

Trends in open-source AI: Join Jon Krohn and a panel of data science icons as they discuss the most exciting and concerning developments in open-source AI. Hear insights from Drew Conway, Jared Lander, Emily Zabor, and JD Long on the transformative potential of AI and its future ... Show More

On the first episode of the OpenAI Podcast, Sam Altman joins host Andrew Mayne to talk about the future of AI: from GPT-5 and AGI to Project Stargate, new research workflows, and AI-powered parenting. 00:00Welcome to the OpenAI Podcast01:00ChatGPT & parenthood04:10AGI, superintel ... Show More

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ... Show More

2025 has thus far been a year of great leaps and advances in AI technology. And Sarah and Elad have spoken with some of the most enterprising founders and scientific minds in the field of AI today. So we’re revisiting a few of our favorite conversations on No Priors so far in 202 ... Show More

Listen as two leading researchers at the cutting edge of computational biology explore breakthrough GPU accelerations that are changing how we understand life's molecular machinery. Chris Dallago, Research Lead at NVIDIA and Visiting Professor at Duke University, and Martin Stein ... Show More